Annual Cash & Cash Equivalents
$66.39 M
+$6.42 M+10.70%
December 31, 2023
Summary
- As of February 7, 2025, TNGX annual cash & cash equivalents is $66.39 million, with the most recent change of +$6.42 million (+10.70%) on December 31, 2023.
- During the last 3 years, TNGX annual cash & cash equivalents has risen by +$38.00 million (+133.91%).
- TNGX annual cash & cash equivalents is now -53.49% below its all-time high of $142.75 million, reached on December 31, 2021.
Performance
TNGX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$53.15 M
+$1.58 M+3.07%
September 30, 2024
Summary
- As of February 7, 2025, TNGX quarterly cash and cash equivalents is $53.15 million, with the most recent change of +$1.58 million (+3.07%) on September 30, 2024.
- Over the past year, TNGX quarterly cash and cash equivalents has dropped by -$13.24 million (-19.94%).
- TNGX quarterly cash and cash equivalents is now -74.07% below its all-time high of $204.97 million, reached on September 30, 2021.
Performance
TNGX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TNGX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.7% | -19.9% |
| 3 y3 years | +133.9% | -7.2% |
| 5 y5 years | +133.9% | -7.2% |
TNGX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -53.5% | +10.7% | -62.8% | +3.1% |
| 5 y | 5-year | -53.5% | +133.9% | -74.1% | +87.3% |
| alltime | all time | -53.5% | +133.9% | -74.1% | +87.3% |
Tango Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $53.15 M(+3.1%) |
| Jun 2024 | - | $51.57 M(-15.7%) |
| Mar 2024 | - | $61.16 M(-7.9%) |
| Dec 2023 | $66.39 M(+10.7%) | $66.39 M(+13.4%) |
| Sep 2023 | - | $58.53 M(-11.4%) |
| Jun 2023 | - | $66.05 M(+15.4%) |
| Mar 2023 | - | $57.25 M(-4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $59.97 M(-58.0%) | $59.97 M(-40.2%) |
| Sep 2022 | - | $100.31 M(-4.1%) |
| Jun 2022 | - | $104.58 M(+4.7%) |
| Mar 2022 | - | $99.91 M(-30.0%) |
| Dec 2021 | $142.75 M(+403.0%) | $142.75 M(-30.4%) |
| Sep 2021 | - | $204.97 M(+622.2%) |
| Dec 2020 | $28.38 M | $28.38 M |
FAQ
- What is Tango Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Tango Therapeutics?
- What is Tango Therapeutics annual cash & cash equivalents year-on-year change?
- What is Tango Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Tango Therapeutics?
- What is Tango Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Tango Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of TNGX is $66.39 M
What is the all time high annual cash & cash equivalents for Tango Therapeutics?
Tango Therapeutics all-time high annual cash & cash equivalents is $142.75 M
What is Tango Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, TNGX annual cash & cash equivalents has changed by +$6.42 M (+10.70%)
What is Tango Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TNGX is $53.15 M
What is the all time high quarterly cash and cash equivalents for Tango Therapeutics?
Tango Therapeutics all-time high quarterly cash and cash equivalents is $204.97 M
What is Tango Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, TNGX quarterly cash and cash equivalents has changed by -$13.24 M (-19.94%)